Based on this background, the present study is set to investigate the roles of the ACE rs4646994, ACTN3 rs1815739, and PPARGC1A rs8192678 polymorphisms in determining the severity of COVID-19 outcomes. This evidence concerns the gene PPARGC1A and COVID-19.